ConductScience.org, home

Paper2425443

Interferons: current status and future directions of this prototypic biological.

Smalley RV and 1 other. Springer Semin Immunopathol, 1986. Cited by 22 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Interferons: current status and future directions of this prototypic biological. Papers, record 2425443. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2425443

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interferons: current status and future directions of this prototypic biological.
PubMed
Journal
Springer Semin Immunopathol
PubMed
Year
1986
PubMed
Publication types
Clinical Trial, Journal Article, Review
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
0.76
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smalley RVR V
2Borden ECE C

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InterferonsMajor topic
Adjuvants, Immunologic
Antibodies, Monoclonal
Breast Neoplasms
Clinical Trials as Topic
Drug Therapy
Female
Humans
Interferon Type I
Interferon-gamma
Killer Cells, Natural
Leukemia, Hairy Cell
Leukemia, Myeloid
Lymphoma
Male
Molecular Weight
Recombinant Proteins
Sarcoma, Kaposi

Source PubMed

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,891,642Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors.Eur J Cancer Clin Oncol1982https://conductscience.org/library/papers/6891642PubMed
26,168,319Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.Blood1981https://conductscience.org/library/papers/6168319PubMed
36,091,102Site-specific mutagenesis of the human fibroblast interferon gene.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6091102PubMed
46,692,412Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system.Cancer Res1984https://conductscience.org/library/papers/6692412PubMed
56,179,076Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6179076PubMed
66,715,911Radiosensitization of human bronchogenic carcinoma cells by interferon beta.J Interferon Res1984https://conductscience.org/library/papers/6715911PubMed
76,470,751Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma.J Clin Oncol1984https://conductscience.org/library/papers/6470751PubMed
86,198,954Interferon as a modifier of estrogen receptors.Ann Clin Lab Sci1984https://conductscience.org/library/papers/6198954PubMed
96,159,812Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.Ann Intern Med1980https://conductscience.org/library/papers/6159812PubMed
106,744,259Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.Cancer Res1984https://conductscience.org/library/papers/6744259PubMed
116,861,260Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6861260PubMed
127,160,583Effects of human fibroblast interferon on human tumors transplanted into nude mice: sensitivity of human tumors to interferon.Gan1982https://conductscience.org/library/papers/7160583PubMed
136,835,320Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.N Engl J Med1983https://conductscience.org/library/papers/6835320PubMed
146,548,079Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma.Am J Med1984https://conductscience.org/library/papers/6548079PubMed
1529,356Preparation of human leukocyte interferon for clinical use.Tex Rep Biol Med1977https://conductscience.org/library/papers/29356PubMed
166,498,762Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanoma.Cancer1984https://conductscience.org/library/papers/6498762PubMed
176,686,847Effects of cloned human leukocyte interferons in the human tumor stem cell assay.J Clin Oncol1983https://conductscience.org/library/papers/6686847PubMed
186,684,502Enhancement of actinomycin D- and cis-diamminedichloroplatinum(II)-induced killing of human fibroblasts by human beta-interferon.Cancer Res1983https://conductscience.org/library/papers/6684502PubMed
196,589,637A species of human alpha interferon that lacks the ability to boost human natural killer activity.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6589637PubMed
206,577,942Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6577942PubMed

See all 62 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
7,510,292Combinations of interferon with platinum complexes: synergistic and antagonistic effects on growth inhibition of MCF-7 and MDA-MB231 breast cancer cells.J Cancer Res Clin Oncol1994https://conductscience.org/library/papers/7510292PubMed
3,533,606Immunogenetics.Experientia1986https://conductscience.org/library/papers/3533606PubMed
1,760,815Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1760815PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2425443

GET https://conductscience.org/api/papers/v1/2425443/references?page=2